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Abstract
Biomaterial scaffold architecture has not been investigated as a tunable source of influence on spinal cord re-
generation. This study compared regeneration in a transected spinal cord within various designed-macro-ar-
chitecture scaffolds to determine if these architectures alone could enhance regeneration. Three-dimensional (3-
D) designs were created and molds were built on a 3-D printer. Salt-leached porous poly(-caprolactone) was
cast in five different macro-architectures: cylinder, tube, channel, open-path with core, and open-path without
core. The two open-path designs were created in this experiment to compare different supportive aspects of
architecture provided by scaffolds and their influence on regeneration. Rats received T8 transections and im-
planted scaffolds for 1 and 3 months. Overall morphology and orientation of sections were characterized by
H&E, luxol fast blue, and cresyl violet staining. Borders between intact gray matter and non-regenerated de-
fect were observed from GFAP immunolabeling. Nerve fibers and regenerating axons were identified with Tuj-
1 immunolabeling. The open-path designs allowed extension of myelinated fibers along the length of the de-
fect both exterior to and inside the scaffolds and maintained their original defect length up to 3 months. In
contrast, the cylinder, tube, and channel implants had a doubling of defect length from secondary damage and
large scar and cyst formation with no neural tissue bridging. The open-path scaffold architectures enhanced
spinal cord regeneration compared to the three other designs without the use of biological factors.
Key words: immunohistochemistry; in vivo studies; neural injury; polycaprolactone; regeneration; scaffold ar-
chitecture; traumatic spinal cord injury 
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Introduction
THE PURPOSE OF THIS STUDY was to investigate the effects ofvaried implant architectures on spinal cord (SC) regen-
eration. Most studies of chronic spinal cord injury (SCI) re-
pair have employed tubes or channels and combined their
material implant with bio-active factors (Hadlock and Sund-
back, 2006; Nomura et al., 2006; Zhang et al., 2005). There
have been no explicit comparisons of architectures which
take into account how scaffold material is distributed with
respect to white and gray matter distribution, though their
physical organization is integral to the functions carried out
by the SC.
Treatments for SCI under investigation include use of
trophic factors, antibodies, enzymes, stem cells, Schwann
cells, or olfactory ensheathing cells (Barnett and Riddell,
2007) to help rebuild the tissue through re-myelination, ax-
onal guidance, or prevention of secondary damage (Hadlock
and Sundback, 2006; Nomura et al., 2006; Zhang et al., 2005).
Cell transplantation and injected factor therapies under in-
vestigation may be limited to small injuries, as survival of
injected cells and residence time of injected factors is often
quite low (Friedman et al., 2002). If the injury is too large, or
in a chronic stage with a large area of secondary damage, a
material scaffold is useful for increasing cell survival and lo-
calizing cells or biologic factors to the target area (Friedman
et al., 2002; Tate et al., 2002).
Several biomaterials have been investigated with varying
architectures and mechanical properties, aimed at delivering
cells or trophic factors to the injured SC and guiding regen-
eration in a longitudinal direction (Bakshi et al., 2004; Carone
and Hasenwinkel, 2006; Flynn et al., 2003; Gelain et al., 2007;
Horn et al., 2007; Houle and Ziegler, 1994; Huang et al., 2005;
Li et al., 2006; Nomura et al., 2006; Stokols et al., 2006; Teng
et al., 2002). Microgrooves in biomaterials play an important
role in contact guidance for neurites in vitro. Studies of chick
embryo neurons in vitro revealed a lower limit on feature
size for neurite alignment to be a 2-m groove depth (Clark
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et al., 1990). This size range was found to be specific for neu-
rites when compared to fibroblasts and endothelial cells
(Clark et al., 1991). An upper limit for neurite alignment in
vitro exists around 10—30 m (Miller et al., 2002; Goldner et
al., 2006). In fact, the narrower the ridge (while still above
single microns) the more concentrated the focal adhesions
are to the ridge, thus aligning the cytoskeleton with the
grooved features (Ito, 1999). Other researchers have shown
in vivo that 20 m diameter collagen micro-filament bundles
integrated into SC tissue and improved functional outcomes
when aligned longitudinally (Yoshii et al., 2003), in contrast
to the poorer performance of perpendicularly oriented fibers
(Yoshii et al., 2004).
Thus far there have been no in vivo comparisons of topo-
graphical features and sizes. However the small nuances in
feature size influences found in vitro with single cell cultures
could well be lost when transferred to in vivo studies. Macro-
scale architecture was the focus of this study, thus micro-
scale topography was fixed based on the studies outlined
above. When micro-scale grooves (microgrooves), were in-
corporated into scaffolds, they were uniformly in the range
of 30—50 m with V-shaped profile; thus, the grooves and
ridges were of tapered width. These grooves, an artifact of
the mold building process, have been controlled to run lon-
gitudinally.
While micro-architectural contact guidance is important,
there have also been indications that macro-scale architec-
ture could play a role. One notable study demonstrated tis-
sue bridges with axonal regeneration through a tube con-
taining no fillers (Tsai et al., 2004), something other studies
using entubulation could not show. This result was possibly
a result of the micro-features of the material, a hydrogel with
a spongy, porous or gel-like inner wall, compared to the ma-
terials used by others previously. This suggests the possi-
bility that a material scaffold could support regeneration
without the use of biologics and that altering the mechani-
cal properties, which also changed the micro-architecture of
the material, could affect the degree of regeneration. Fur-
thermore, these researchers report that an increase in surface
area from a hollow channel to a tubes-within-channels
(TWC) design with four small inner tubes increases func-
tional recovery and regeneration with out biologics (Tsai et
al., 2006). This may seem contrary to other reports in which
the surface area is much greater than the TWC design, such
as microporous oriented channels which do not support re-
generation (Hurtado et al., 2006). However, the change in
surface area also changes the macro-architecture. We pro-
pose that not just the surface area, but the structure of the
surfaces in relation to the anatomy of the SC may play a role
in the regeneration.
The organization and reconnection of different tracts in
the SC are important to functional recovery. For example,
lateral and ventral corticospinal tracts are most important to
recovery of locomotor function, while sparing of dorsal tracts
provide less improvement (Kaegi et al., 2002; Mori, 1992;
Noga et al., 1991; Schucht et al., 2002). When evaluating SCI
in patients and their potential treatments, these types of
anatomical distinctions have a great effect on the degree of
functional recovery.
Various injury models have been used to study different
aspects of injury and regenerative capacity. Contusion, hemi-
section, and complete transection are the most common
models (Hadlock and Sundback, 2006; Nomura et al., 2006;
Zhang et al., 2005). While each of the models has repro-
ducible effects, it is more difficult in the contusion and hemi-
section models to determine if recovery is due to sparing and
compensatory sprouting or new regeneration. Though con-
tusions and hemisection models can be more clinically rele-
vant, in cases where proof of concept and proof of regener-
ation is needed, the complete transection model is often
useful, and is employed in this study.
Newly severed axons have regenerative capacity in the
first few days but meet with restrictive environments such
as myelin inhibitory factors and a quickly growing glial scar,
which prevent axonal extension and complete regeneration
to their original targets (Busch and Silver, 2007; Maier and
Schwab, 2006; Schwab et al., 2006; Schwab, 2002). Different
neurotrophic factors (Thoenen, 1991) are being investigated
to make the injured environment more permissive to axonal
regeneration (Barritt et al., 2006; El Maarouf et al., 2006;
Novikova et al., 2003). The local balance of permissive and
inhibitory factors should be tipped toward permissive (Jones
et al., 2003). While bio-active factors will indeed play a strong
role in SC regeneration, the architecture of implant material
may play an important, and more easily controlled role as
well.
This study has developed a method of manufacturing SC
implants with very specific and varied designs that take into
account white matter tracts. These new SC implant designs
were compared to single and multiple channel architectures
as well as a randomly porous cylindrical sponge.
The novel designs were conceived to provide surface area
in key locations with grooves to direct growth while de-
creasing the barriers which might be presented by designs
like multi-channeled scaffolds (Nomura et al., 2006) or cylin-
drical sponges (Patist et al., 2004). In fact, the new designs
actually have less total longitudinal surface area than the
other designs. Instead, they take advantage of the circum-
ferential location of the white matter and the early secondary
death of the gray matter. The new designs in this study have
an open path for the lateral funiculi where the corticospinal
tracts descend, while one contains a central core to provide
an added surface for guidance of nerve fibers from that re-
gion. In a typical injury the center of the cord dies first, leav-
ing the exterior white matter tracts to cave in, resulting in a
narrowing at the defect site (Maier and Schwab, 2006;
Schwab et al., 2006). The open-path scaffold with a core was
designed to support the white matter tracts from the center.
This is in contrast to the tube, channel, and cylinder designs
with surfaces and obstructions in various locations as well
as entubulation methods, which provide surface contact
guidance from the outside of the cord. The cylindrical core
present in one open-path design is suspended in the center
of the defect by fins from the top and bottom shells (Fig. 1).
In order to maintain a consistent implantation method, no
entubulation was used. Instead, architectures with random
or contrasting support were designed as comparisons.
The open-path designs allowed extension of myelinated
fibers along the length of the defect both exterior to and in-
side the scaffolds and maintained their defect size over 3
months. In contrast, the cylinder, tube, and channel implants
had a doubling of defect length from secondary damage and
large scar and cyst formation with no neural tissue bridging.
The benefits of the open-path designs could be due only to
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differences in macro-architecture, as material and microar-
chitecture were the same in all implants and no biological
factors were used.
Methods
Scaffold Design and Fabrication
Implants were made of PCL (50,000 kDa MW; Solvay
Chemicals Inc., Houston, TX), dissolved in acetone, (13% wt.)
and 180—250 m sieved salt crystals were used for porogen
leaching. The general shape and size of the implants was a
4-mm-long cylinder with a 2.8-mm diameter. Five designs
were used: cylinder, hollow tube, five-channel, open-path
with core, and open-path with no core (Fig. 1A). Within the
walls of each macro-design (gray areas in Fig. 1A), the im-
plants were given a porous structure by salt leaching. Briefly,
salt was poured into the molds, then solvent-dissolved PCL
was injected through ports into the mold using a 30-gauge
syringe needle multiple times until the mold was filled with
PCL. All the salt crystals were packed prior to polymer in-
jection and in contact with each other, forming random con-
nections between the resulting pores. After polymer injec-
tion and solvent evaporation, all the salt was removed by
soaking the scaffold in 70% ethanol, leaving crystal-shaped
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FIG. 1. Design and fabrication of macro-architectures for spinal cord implants. (A) Axial view of designs for cylinder (i),
tube (ii), channel (iii), open-path with core (iv), and open-path without core (v). (B) Wireframe view of a mold for the chan-
nel design, a funnel is built into the top through which salt and polymer are poured to fill the mold. (C) The open-path
without core mold design with polymer and salt inlet (i), oblique view (ii) and side view (iii). (D) The open-path with core
design (i), oblique view (ii) and side view (iii). SEM micrographs for cylinder (E), tube (F), channel (G), open-path with
core (H), and open-path without core (I) scaffolds after fabrication.
pores where the salt crystals were. The complete removal of
the salt, evidenced by pliability of the scaffold and translu-
cence in water, further supports that the pores are intercon-
nected throughout. The random organization and crystalline
shape of the pores can be seen in scanning electron mi-
croscopy (SEM) images (Fig. 1). While these salt-generated
pores do not uniformly traverse the entire length of the scaf-
folds, channels and other designed architectures can be
specifically controlled with the design of the molds. Thus,
the use of salt and designed molds creates two layers of
porosity.
To achieve the intricate architectures, implants were de-
signed in Rhinoceros software (McNeel North America,
Seattle, WA), and wax molds were built on a 3D Solid-
scape printer (Solidscape Inc., Merrimack, NH; Fig. 1B—
D). To impart longitudinal microgrooves, molds were
built sideways with a funnel on top for pouring in salt and
the polymer (Fig. 1B). Cylinder design implants were
made in Teflon molds packed with salt and had no mi-
crogrooves (Fig. 1E). Microgrooves are an artifact of the
layer-by-layer mold printing process. The programmed
layer thickness was set to 38.1 m. A groove is generated
in the z-direction between each layer in the mold. The
grooves are then transferred in the casting process to the
actual polymer scaffold (Fig. 1F—I). The excess polymer
was trimmed from each implant, and wax was dissolved
in Bio-act (Solidscape Inc. Merrimack, NH). The Bio-act
and salt particles were cleaned out with several washes of
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FIG. 2. Control defect, no scaffold implant, at 1 and 3 months, H&E stained and immunolabeled. Caudal end is always
to the right. (A) 1 month H&E stained. (B) 3 months H&E stained section with corresponding regions (boxed) immunola-
beled for GFAP (C), and Tuj-1 (D,E).
70% ethanol and agitation, and implants were stored ster-
ilized in fresh 70% ethanol. Prior to surgery, implants were
transferred to sterile saline.
PCL is a biocompatible polymer that degrades by hydrol-
ysis. We have shown its biocompatibility is greater in the rat
brain compared with its highly used family member, PLGA
(Wong, Hollister, et al., 2007). It is easily processed to have
the desired architectures for this study. The high molecular
weight chosen here ensures that the architecture, the focal
point of this study, is maintained for the duration of the ex-
periments. In future studies it may be desirable to have a
more quickly degrading scaffold. This material can be used
with a lower molecular weight or surface treatment to in-
crease its degradation rate while its degradation products,
and any tissue reaction to them, will be maintained. When
PCL is solvent cast with porogen leaching, the resulting scaf-
fold is spongy and pliable, yet can still be surgically manip-
ulated.
The total longitudinal surface areas for each geometrical
design, not calculating for surface roughness and microp-
ores, were as follows (in mm2): tube, 60.3; channel, 66.6;
cylinder, 37.7; open-path with core, 48.3; and open-path
without core, 44.8. The open path designs have nearly 30%
less surface area than the tube and channel, and roughly 20%
greater surface area than the cylinder.
Surgical Implantation
Female Sprague Dawley rats (200—250 g) were anesthe-
tized with isofluorane and intubated. Following a laminec-
tomy from T7 to T9, SCs were completely transected at T8
with a 2-mm-long removal of tissue. With subsequent tissue
retraction, the gap was 4 mm long. Control groups received
no implant. Implants were sutured to proximal and distal
stumps, and then covered with Durepair (Medtronic, Min-
neapolis, MN). Daily bladder expression, antibiotics, and
husbandry attention were administered as needed. Each time
point and group contained n  3 replicate animals. Deaths
reduced the number of rats in the channel group to one rat
at 1 month. Rats were sacrificed at 1 and 3 months by tran-
scardial perfusion. SCs were cryosectioned longitudinally for
immunohistochemistry and staining onto gelatin coated
slides. All surgery, post-surgical recovery and euthanasia
were performed according to a protocol approved by the
University of Michigan Committee on the Use and Care of
Animals.
Histology and Immunohistochemistry
Stains and antibodies used were hematoxylin and alco-
holic eosin (H&E), Luxol Fast Blue (LFB) (myelin stain) and
Cresyl Violet (Nissl substance, neuron stain), rabbit anti-
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FIG. 3. Cylinder implant at 1 and 3 months, sagittal sections H&E stained and immunolabeled for GFAP and Tuj-1. Cau-
dal end is always to the right. (A) 1 month H&E stained. (B) 3 months H&E stained with corresponding regions (boxed)
immunolabeled for GFAP (C,E), and Tuj-1 (D).
GFAP for astrocytes (G9269 Sigma), mouse anti-Tuj-1 for ax-
ons (MMS-435P Covance, Berkeley, CA) with a Vecta-stain
ABC kit (Vector Labs, Burlingame, CA), and biotinylated
Alexa-488 (Invitrogen/Molecular Probes, Carlsbad, CA) for
fluorescent visualization. Non-specific binding was blocked
with 5% donkey serum and 3% bovine serum albumin (Jack-
son ImmunoResearch, West Grove, PA). Images were taken
using a Spot camera and Spot Advanced software (Diag-
nostic Instruments, Sterling Heights, MI).
Statistical Analysis
Defect lengths were measured from serial sections labeled
with GFAP to identify the extent of degeneration of the cen-
tral core of gray matter. Because of the poor connectivity be-
tween some stumps of the control group and easy disrup-
tion during tissue handling, defect lengths for the control
group were not measured (Fig. 2). Two-way analysis of vari-
ance (ANOVA) was carried out on defect length measure-
ments with time and group as independent variables.
Tukey’s Least Significant Difference post-hoc analysis was
used for multiple comparison between groups if significance
levels were below p  0.05.
For each animal at 3 months, multiple stained and labeled
slides were evaluated to determine presence or absence for
each animal with the following indications: H&E-stained tis-
sue growth bridging the entire defect through or around the
implant without break (tissue ingrowth and continuity),
Luxol Fast Blue stained myelinated fibers with appropriate
morphology extending into, across, or within the defect site
(myelinated fibers), GFAP-labeled cells found within the de-
fect site beyond the ends of the implant (astrocyte immigra-
tion), Tuj-1—labeled fibers within or around the defect site
beyond the ends of the implant but not necessarily extend-
ing the entire length (axonal infiltration). With n  3 for each
group, not including the control, each assessment is given
one “” for each animal in which the quality was found on
at least one slide. If none of the animals in that group qual-
ified a “”, the entire group received one “-”. These assess-
ments are summarized in Table 1.
Results
From H&E staining and gross images, connectivity be-
tween the stumps was obtained in all implants to varying
degrees. Much of the growth for the cylinder (Fig. 3), and
tube and channel groups (Fig. 4) occurred along the out-
side of these implants. Much of the porous interior walls
were filled with cellular debris, macrophages, and fibro-
blast-like cells as observed from H&E staining at 1 month
(Figs. 3A and 4A,H). By the 3-month time point, several of
these implants showed secondary cell death within and
around them (Figs. 3B and 4B,I). A high degree of secondary
death was evident in these three groups at both ends of the
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FIG. 4. Tube and channel implants at 1 and 3 months, sagittal sections H&E stained and immunolabeled for GFAP and
Tuj-1. Caudal end is always to the right. (A) Tube section at 1 month H&E stained. (B) Tube section at 3 months H&E
stained with correspondeing regions (boxed) immunolabeled for GFAP (C,G) and Tuj-1 (D—F). (C) Channel section at 1
month H&E stained. (D) Channel section at 3 months H&E stained with corresponding regions (boxed) immunolabeled for
GFAP (J,N) and Tuj-1 (K—M).
injury. In particular, fibrous capsules formed around the
cylinder design scaffolds after 3 months (Fig. 3B). GFAP an-
tibodies labeled reactive astrocytes in intact SC and became
diffuse and non-existent closer to and within the scaffold
as tissue was degenerating and fibrous tissue had grown in
Figure 4C,G,J,N. Tuj-1—labeled axons were found only in
the remaining SC stumps (Fig. 4D,K,L). Oriented tissue
within the tube and channels contained no axons (Fig.
4E,F,M).
In contrast, tissue grew interiorly along the entire length
of both open-path implants and appeared well connected
(Fig. 5). Because of the uncommon architecture of these scaf-
folds, diagrams of orientation and approximate planes of sec-
tioning have been provided for each of the open-path de-
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FIG. 5. Open-path designs with and without core, sagittal sections stained and immunolabeled. Arrows indicate rostral
to caudal direction. (A) Two neighboring sections (orientation diagramed) from open-path without core at 1 month, H&E
(A-1) and LFB (A-2) stained. (B) Four neighboring sections (orientation diagramed) from open-path without core at 3 months,
H&E (B-2, B-4) and LFB (B-1, B-3) stained. Section shown in B-2 has corresponding regions (boxed) immunolabeled for
GFAP (B-5) and Tuj-1 (B-6, B-7, B-8). (C) Two sections from a different animal from open-path without core 3-month group
H&E (C-1) and LFB (C-2) stained. (D) Two neighboring sections (orientation diagramed) from open-path with core at 1
month, H&E (D-1) and LFB (D-2) stained. (E) Four neighboring sections (orientation diagramed) from open-path without
core at 3 months, H&E (E-1, E-2, E-3) and LFB (E-4) stained. Section shown in E-3 has corresponding regions (boxed) im-
munolabeled for GFAP (E-5) and Tuj-1 (E-6, E-7, E-8, E-9). (F) Section from a different animal from open-path with core 3-
month group H&E (F-1) stained with corresponding regions (boxed) immunolabeled for GFAP (F-2) and Tuj-1 (F-3).
signs along with images of neighboring sections (Fig.
5A,B,D,E). Histological results were consistent in replicate
animals. An additional specimen is shown for each open-
path design at the 3-month time point for comparison (Fig.
5C,F). The gross shape and size of the SC at the implant site
was similar to uninjured areas of the cord, unlike the other
three implant groups where large cysts and fibrotic tissue
formed around the implants and their ends. There was less
necrosis and scar tissue at both ends of the open-path im-
plants, and neural tissue from both proximal and distal
stumps entered and grew around the implants. Considerable
tissue tracts along the periphery of the defect and the out-
side edges of the scaffolds contained intact Tuj-1—positive
myelinated axonal fibers, though they never appeared to
connect on the distal stump. Some of the thicker growths
around the edges of the open-path designs could have been
spinal nerves from either dorsal or ventral nerve roots, but
instead of exiting the spinal canal, they merged with the scaf-
folds along the length of the defect before leaving the SC
(Fig. 5). There were also Tuj-1—labeled axons within the
open-path with core scaffolds, and fibers were observed
straddling the edge of the bottom shell on both of its sur-
faces (Fig. 5F-3). The shell thickness was 200 m.
Defect lengths measured from GFAP-labeled serial sec-
tions after 3 months in vivo showed that defects with open-
path designs maintained their original lengths from the im-
plant size of 4 mm (Fig. 6). Defects with the three closed
designs had nearly a doubling of defect length from the orig-
inal implant size (p  0.002). As most secondary cell death
occurs in the first few weeks, there was no significant dif-
ference in defect lengths over the two time points, 1 and 3
months (p  0.54); thus, only 3- month data is reported.
Presence or absence of the different types of labeling or
staining was assessed from all the sections for each replicate
sample at 3 months. These qualitative assessments are sum-
marized in Table 1 and provide a semi-quantitative summary
of the histological data.
Discussion
The open-path designs both with and without core had a
beneficial effect on the secondary injury progression by mea-
sure of the defect length. Overall morphological appearance
of the cord specimens with these implants was more con-
nected and less fibrous. Axonal regeneration was seen within
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TABLE 1. THREE-MONTH ASSESSMENT OF HISTOLOGICAL DATA FROM EACH REPLICATE SAMPLE
Tissue ingrowth Astrocyte Axonal
and continuity Myelinated immigration infiltration
(H&E) fibers (LFB) (GFAP) (Tuj1)
Cylinder (n  3)    
Tube (n  3)    
Channel (n  3)    
Open-path without    
core (n  3)
Open-path with    
core (n  3)
Presence of staining or labeling within the defect site in one or more section of each replicate is indicated by a () for each replicate animal,
whereas a () indicates none found. In the case of tissue ingrowth and continuity, fibrous tissue continuity between stumps and scaffold on
both ends was assigned a (), whereas discontinuity in all groups received a ().
FIG. 6. Defect lengths and illustrations of possible interac-
tions. (A) Average shortest distance between GFAP labeled
intact cord stumps at 3 months, open-path designs (*) sig-
nificantly lower than closed designs (**) (p  0.002). (B) Il-
lustration of open-path with core scaffold and its orientation
within the defect. Nerve roots or regenerating white matter
tracts from the lateral funiculus could possibly crawl along
the inner core of the scaffold to bridge the defect. (C) Mod-
ified designs (dotted lines) could accommodate contusion
(left) or hemisection (right) injury models while maintaining
the same principles of complete transection designs.
and around these implants, and particularly robust fibers
were observed crossing the defects around the implants.
These promising regenerative results were in complete con-
trast to the results in the other three designs whose defect
lengths grew to 7 mm, and had no neural tissue regenera-
tion across the defect site.
The completely transected and untreated control group
has been unrepresented in data analysis in SC studies with
4-mm gap lengths (Nomura et al., 2006; Tsai et al., 2004, 2006)
or left out completely from the study (Oudega et al., 2001)
because of its lack of information. Untreated transections do
not form good bridges, show no specific labeling of neural
cell types, and are unsuccessful at regeneration. In terms of
cell death, complete transection injuries have also shown a
40% tissue loss and a 0.79 _ 0.19 mm axonal die-back on
both ends after 8 weeks (Oudega et al., 1999). One would ex-
pect the loss to be greater if tissue is also removed as in the
case of our study and other similar studies. Thus, at best, one
expects that the untreated control groups would have axonal
die-back and tissue loss resulting in the 4-mm gap expand-
ing to or in excess of 5.6 mm, likely greater. This is roughly
the extent of our closed designs and that of the reported gap
width of Tsai et al. (2004), ranging from 6 to 8 mm. These
examples indicate that the open-path designs do improve re-
generation over the other designs and over no treatment at
all.
To further differentiate the two open-path designs, the im-
plant with a central core had more robust nerve fiber exten-
sion across the defect site both around the outside of the im-
plant and within the scaffold itself. The design without a core
showed only bundles of fibers along the outside. Though not
statistically significant, the open-path with core implant even
showed a decrease in defect length, indicating some regen-
eration of the central region of the SC.
Though many nerve fibers were seen crossing the open-
path scaffolds, it is possible that they were not newly re-
generated fibers. Because the open-path designs were open
rather than closed like the other three, there was space for
nerve roots to potentially merge into the defect site prior to
their exit (Fig. 6B). It is possible that these nerve roots served
a protective role for the remaining cord, which could have
prevented enlargement of the defect length. One of the most
promising treatments for SCI currently is transplantation of
peripheral nerve grafts (Houle et al., 2006; Kuo et al., 2007;
Levi et al., 2002). Specifically, after a preconditioning injury,
the Schwann cells of these grafts have been shown to mi-
grate from the graft and myelinate the axons of injured SC
(Dinh et al., 2007; Fukunaga et al., 2004). If those nerve fibers
crossing the defect of the open-path designs were indeed un-
injured spinal roots which became physically engaged in the
defect along the scaffolds, their proximity and activation due
to the injury could have promoted some neuroprotection.
This type of interaction between the native peripheral ner-
vous system and the injured SC would be impossible with
entubulation methods, which enclose and protect the SC
from exterior perturbations. Still the spared spinal nerve
roots cannot account for the un-bundled and disorganized
axonal growth found within the open-path with core scaf-
folds (Figs. 5E-7, 5E-9, and 5F-3).
The open-path with core design slightly out-performed the
open-path without a core. The difference between the two
designs is the central cylindrical core. The core could have
provided an additional surface for guiding white matter
tracts from a convenient position in the inside of the cord,
as intended.
The three closed designs were unsuccessful at providing
an environment conducive to regeneration, even though
both the tube and the channel design had greater surface ar-
eas than the open-path designs. The cylinder implant re-
sulted in extreme defect enlargement and fibrous tissue en-
capsulation, likely worse than doing nothing at all. The tube
and channel designs did allow oriented tissue to grow
within, but it was mostly fibrous and not neural. The tube
walls essentially abutted the white matter tracts, in a simi-
lar fashion as the shells of the open-path designs. However,
the tube walls were thicker than the open-path shells: 650
m compared to 200 m. In addition, the tube walls went
all the way around and were not open. The thickness of the
walls may have played a part in the switching of roles from
barrier, in the tube, to guiding surface, in the open-paths. It
should be noted that the tube was not representative of en-
tubulation methods, which push cord ends into the tubes.
Because we wanted to maintain a consistent implantation
method, we did not make an entubulation implant though
it is more commonly used, generally in combination with bi-
ological factors or cells. However, the contact guidance from
an entubulating implant is solely exterior to the native SC.
This type of contact is normally provided by the dura and
spine and is not a cue for regeneration but a cue for enclo-
sure. Entubulation can be considered secondary to the in-
ternal architecture, as one can use architecture encased in a
tube, as with the TWC described earlier (Tsai et al., 2006). It
may be beneficial to eventually incorporate both. Tubes have
a tendency to collapse (Oudega et al., 2001), or pinch and ob-
struct cerebrospinal fluid (CSF) flow (Nomura et al., 2006) in
the current animal models where laminectomy is performed
on an uninjured rat. But perhaps in clinical situations, where
the spine may also be damaged, a tube that encloses the SC
implant may also fuse with the spine to provide bone re-
generation. Interestingly, while it has been reported that ax-
ons regenerated through an entubulating implant, the stump
distance reported was comparable to the stump distances
measured in our study for the tube and channel designs,
roughly 6—8 mm, though all started with a 4-mm defect
(Tsai et al., 2004). While tissue can bridge the defect through
any design, the original stumps regressed with the closed
designs presented here just as with the entubulation method,
in contrast to the open-path designs.
While multi-channeled scaffolds aim to increase surface
areas to enhance guidance and carry trophic factors, the five
channels with 450-m diameters presented in this study did
not effectively integrate with the host tissue. Channels
spaced closer and with greater density may be an improve-
ment on that design, and have shown promise when used
in conjunction with cells or trophic factors (Stokols et al.,
2006). But the difference in surface area occurs in conjunc-
tion with a change in architecture. In fact, though the tube
and channel designs had a greater surface area, the open-
path designs had a much greater effect on regeneration, fur-
ther evidence that macro-architecture and targeted contact
guidance are more important than total surface area.
If modifying the architecture of a non-permissive mater-
ial, a PCL salt-leached sponge, can allow robust bridging and
inhibition of secondary damage, the effects of biologic fac-
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tors could be greatly enhanced. The use of more diverse ar-
chitectures may provide a missing link in the chain of com-
ponents currently being studied in SC regeneration. Apply-
ing similar principles of architecture choice based on white
and gray matter delineations to other injury models like con-
tusion or hemisection might produce designs such as those
displayed in Figure 6C. Porosity could be generated by al-
ternate methods, and different materials could be employed
using the same mold.
In summary, the novel open-path designs allowed greater
penetration of GFAP labeled neural tissue from both stumps
and caused less scarring than the conventional implant de-
signs. The open-path designs provided contact guidance us-
ing less material and allowed nerve fibers to extend across
the entire defect length. These data suggest that implant ar-
chitecture can be designed in more diverse ways to influence
the regeneration of SC tissue without the use of biological
factors. This study examined only architectural effects in SC
transection. Future applications of these designs could in-
clude cell seeding or trophic factor impregnation. Also com-
posite implants could enhance the guided regeneration of
white matter while supporting the gray matter with cells or
hydrogels infused in the core and or other specific areas of
the scaffold.
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